MENU

OCS Oculis Holding AG Forecast, Technical & Fundamental Analysis

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care... Show more

OCS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
OCS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

OCS is expected to report earnings to rise 150.88% to -40 cents per share on November 05

Oculis Holding AG OCS Stock Earnings Reports
Q3'26
Est.
$-0.40
Q2'26
Beat
by $0.23
Q1'26
Beat
by $0.08
Q3'25
Beat
by $0.14
Q2'25
Missed
by $0.03
The last earnings report on August 06 showed earnings per share of -15 cents, beating the estimate of -39 cents. With 118.36K shares outstanding, the current market capitalization sits at 587.21M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
Bahnhofstrasse 20
Phone
+41 417113960
Employees
60
Web
https://www.oculis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AVDNX17.850.13
+0.73%
Avantis® International Equity G
TEMEX19.75N/A
N/A
Franklin Mutual Beacon C
KMVAX36.98N/A
N/A
Kirr Marbach Partners Value
VREMX7.73N/A
N/A
Virtus SGA Emerging Markets Equity R6
JUEPX27.77N/A
N/A
JPMorgan US Equity R3

OCS and Stocks

Correlation & Price change

A.I.dvisor tells us that OCS and JSPR have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OCS and JSPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
-6.63%
JSPR - OCS
33%
Poorly correlated
-5.77%
FTH - OCS
32%
Poorly correlated
-4.00%
GRI - OCS
30%
Poorly correlated
-2.06%
PRAX - OCS
29%
Poorly correlated
-1.18%
JBIO - OCS
28%
Poorly correlated
-6.53%
More